carbamates and amelubant

carbamates has been researched along with amelubant in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (60.00)29.6817
2010's4 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anderskewitz, R; Birke, FW; Jennewein, HM; Meade, CJ; Speck, GA1
Alten, R; Emmerich, J; Gromnica-Ihle, E; Pohl, C; Roscher, R; Schmolke, B; Sigmund, R; Steffgen, J; Steinmann, G1
Bäck, M; Bränström, R; Bu, DX; Hansson, GK; Sheikine, Y; Yan, ZQ1
Schmitt-Grohé, S; Zielen, S1
Alten, RH; Bensen, WG; Bombardieri, S; Brown, JP; de-Miquel, G; Díaz-González, F; Dougados, M; Durez, P; Leledy, C; Ortiz, P; Polmar, SH; Salin, L; Sibley, JT; Sigmund, R; Staab, A1
Bäck, M; Brink, C; Feldman, L; Hlawaty, H; Jacob, MP; Letourneur, D; Louedec, L; Michel, JB1
Aktürk, FF; Bilton, D; Born, T; Bragonzi, A; Cigana, C; Döring, G; Elborn, JS; Gilpin, D; Heyder, S; Kohlhäufl, M; Konstan, MW; Loebinger, MR; Paroni, M; Pier, GB; Schmidt, A; Smaczny, C; Tunney, MM; Ulrich, M; Wagner, TO1
Bessi, VL; Bitencourt, CS; Borgeat, P; Faccioli, LH; Hamdan, L; Huynh, DN; Lefebvre, JS; Lévesque, T; Marleau, S; Ménard, L; Sohouhenou, F1
Bhattacharya, S; Döring, G; Hamilton, A; Heltshe, SL; Hilliard, KA; Koker, P; Konstan, MW; Lands, LC; Staab, A1
Bäck, M; Hermansson, A; Hlawaty, H; Ketelhuth, DF; Letourneur, D; Yan, ZQ1

Reviews

1 review(s) available for carbamates and amelubant

ArticleYear
Leukotriene receptor antagonists in children with cystic fibrosis lung disease : anti-inflammatory and clinical effects.
    Paediatric drugs, 2005, Volume: 7, Issue:6

    Topics: Adolescent; Amidines; Asthma; Bronchial Hyperreactivity; Carbamates; Child; Child, Preschool; Clinical Trials as Topic; Cystic Fibrosis; Humans; Infant; Infant, Newborn; Inflammation Mediators; Leukotriene Antagonists; Neutrophils; Respiratory Tract Infections; Virus Diseases

2005

Trials

3 trial(s) available for carbamates and amelubant

ArticleYear
Inhibition of leukotriene B4-induced CD11B/CD18 (Mac-1) expression by BIIL 284, a new long acting LTB4 receptor antagonist, in patients with rheumatoid arthritis.
    Annals of the rheumatic diseases, 2004, Volume: 63, Issue:2

    Topics: Adolescent; Adult; Aged; Amidines; Area Under Curve; Arthritis, Rheumatoid; Carbamates; Double-Blind Method; Female; Humans; Leukotriene Antagonists; Leukotriene B4; Macrophage-1 Antigen; Male; Middle Aged; Neutrophils; Time Factors

2004
Clinical trial of a leucotriene B4 receptor antagonist, BIIL 284, in patients with rheumatoid arthritis.
    Annals of the rheumatic diseases, 2007, Volume: 66, Issue:5

    Topics: Administration, Oral; Adolescent; Adult; Aged; Amidines; Arthritis, Rheumatoid; Carbamates; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Receptors, Leukotriene B4; Treatment Outcome

2007
A randomized double blind, placebo controlled phase 2 trial of BIIL 284 BS (an LTB4 receptor antagonist) for the treatment of lung disease in children and adults with cystic fibrosis.
    Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2014, Volume: 13, Issue:2

    Topics: Adolescent; Adult; Amidines; Anti-Inflammatory Agents; Bronchoalveolar Lavage Fluid; Carbamates; Child; Cystic Fibrosis; Disease Progression; Double-Blind Method; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Early Termination of Clinical Trials; Female; Humans; Inflammation; Male; Receptors, Leukotriene B4; Respiratory Function Tests; Risk Assessment; Sputum; Treatment Outcome

2014

Other Studies

6 other study(ies) available for carbamates and amelubant

ArticleYear
In vitro and in vivo pharmacological characterization of BIIL 284, a novel and potent leukotriene B(4) receptor antagonist.
    The Journal of pharmacology and experimental therapeutics, 2001, Volume: 297, Issue:1

    Topics: Amidines; Animals; Anti-Inflammatory Agents; Benzoates; Calcium; Carbamates; Cell Line; Chemotaxis, Leukocyte; Guinea Pigs; Humans; Leukotriene B4; Macrophage-1 Antigen; Neutrophils; Rabbits; Rats; Receptors, Leukotriene B4; Species Specificity; Succinates

2001
Leukotriene B4 signaling through NF-kappaB-dependent BLT1 receptors on vascular smooth muscle cells in atherosclerosis and intimal hyperplasia.
    Proceedings of the National Academy of Sciences of the United States of America, 2005, Nov-29, Volume: 102, Issue:48

    Topics: Amidines; Analysis of Variance; Animals; Atherosclerosis; Blotting, Western; Carbamates; Carotid Artery Injuries; Cell Movement; Electrophysiology; Fatty Alcohols; Glycols; Humans; Hyperplasia; Leukotriene B4; Male; Muscle, Smooth, Vascular; NF-kappa B; Patch-Clamp Techniques; Polymerase Chain Reaction; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Leukotriene B4; Receptors, Purinergic P2; Signal Transduction; Tunica Intima; Up-Regulation

2005
Leukotriene receptor antagonism and the prevention of extracellular matrix degradation during atherosclerosis and in-stent stenosis.
    Arteriosclerosis, thrombosis, and vascular biology, 2009, Volume: 29, Issue:4

    Topics: Administration, Oral; Amidines; Angioplasty, Balloon; Animals; Carbamates; Carotid Artery, Common; Carotid Stenosis; Cell Line; Cell Movement; Cell Proliferation; Cholesterol, Dietary; Disease Models, Animal; Extracellular Matrix; Humans; Hyperplasia; Leukotriene Antagonists; Leukotriene B4; Macrophages; Male; Mammary Arteries; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Organ Culture Techniques; Rabbits; RNA Interference; RNA, Small Interfering; Secondary Prevention; Stents; Time Factors; Transfection

2009
BIIL 284 reduces neutrophil numbers but increases P. aeruginosa bacteremia and inflammation in mouse lungs.
    Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2014, Volume: 13, Issue:2

    Topics: Adult; Amidines; Animals; Anti-Inflammatory Agents; Bacteremia; Carbamates; Cystic Fibrosis; Disease Models, Animal; Female; Humans; Inflammation; Leukocyte Count; Lung; Male; Mice; Neutrophils; Pseudomonas aeruginosa; Pseudomonas Infections; Receptors, Leukotriene B4; Treatment Outcome

2014
Cooperative role of endogenous leucotrienes and platelet-activating factor in ischaemia-reperfusion-mediated tissue injury.
    Journal of cellular and molecular medicine, 2013, Volume: 17, Issue:12

    Topics: Amidines; Animals; Azepines; Biological Assay; Carbamates; Dermis; Disease Models, Animal; Extravasation of Diagnostic and Therapeutic Materials; Extremities; Inflammation; Leukotriene B4; Leukotrienes; Male; Mice; Mice, Inbred C57BL; Myocardial Ischemia; Neutrophil Infiltration; Platelet Activating Factor; Platelet Membrane Glycoproteins; Propionates; Quinolines; Rabbits; Receptors, G-Protein-Coupled; Receptors, Leukotriene; Reperfusion Injury; Triazoles

2013
The leukotriene B4 receptor (BLT) antagonist BIIL284 decreases atherosclerosis in ApoE-/- mice.
    Prostaglandins & other lipid mediators, 2015, Volume: 121, Issue:Pt A

    Topics: Amidines; Animals; Apolipoproteins E; Atherosclerosis; Carbamates; Cytokines; Male; Matrix Metalloproteinases; Mice; Receptors, Leukotriene B4; RNA, Messenger; Signal Transduction; Tissue Inhibitor of Metalloproteinases

2015